Argenx
ARGX
#443
Rank
NZ$99.35 B
Marketcap
NZ$1,580
Share price
0.54%
Change (1 day)
9.96%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

We have found no dividend yield history for this company